Leptin and Endothelial Function
NCT00121433 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2006-06-27
Summary
The purpose of this trial was to determine if injections of leptin would improve vascular function in normal-weight, healthy volunteers.
Conditions
- Healthy
Interventions
- DRUG
-
leptin
Sponsors & Collaborators
- collaborator INDUSTRY
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-09-30
- Completion
- 2004-12-31
More Related Trials
-
CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy
NCT02654977 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Metreleptin in Type 1 Diabetes Mellitus
NCT01268644 ·Status: TERMINATED ·Phase: PHASE1
-
Short-term Effects of Leptin in People With Lipodystrophy
NCT01778556 ·Status: COMPLETED ·Phase: PHASE2
-
Leptin to Treat Severe Insulin Resistance - Pilot Study
NCT00027456 ·Status: COMPLETED ·Phase: PHASE2
-
Tetranectin as a Novel Obesity-associated Adipokine for Regulating Lipid Accumulation
NCT03229044 ·Status: COMPLETED
-
Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
NCT01021865 ·Status: COMPLETED
-
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
NCT02262806 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Cardiovascular Effects of GLP-1 Receptor Activation
NCT03101930 ·Status: COMPLETED ·Phase: PHASE4
-
Human Vasodilatory Effect of GLP-1
NCT03502083 ·Status: COMPLETED ·Phase: NA
-
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
NCT02262832 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
NCT01149421 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Human Leptin Replacement
NCT00657605 ·Status: COMPLETED ·Phase: PHASE2
-
Expanded Access Metreleptin Study
NCT02404896 ·Status: AVAILABLE
-
To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
NCT02299388 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans
NCT02468999 ·Status: COMPLETED ·Phase: NA
-
Effects of Leptin Replacement in Children
NCT00659828 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism
NCT02721888 ·Status: TERMINATED ·Phase: PHASE4
-
Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects
NCT02053935 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Metformin on Lactate Metabolism
NCT00390273 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Insulin on Endothelin-Dependent Vascular Tone in the Forearm Circulation
NCT00001624 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison Between Breath Acetone and Blood Beta-Hydroxybutyrate
NCT03299543 ·Status: COMPLETED
-
Leptin in Human Energy and Neuroendocrine Homeostasis
NCT00265980 ·Status: TERMINATED ·Phase: NA
-
Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects
NCT00822003 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance
NCT00085982 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics
NCT02042664 ·Status: COMPLETED ·Phase: PHASE3